Steps to complete the survey:
1. Click on Sign In button and login/register from your account.
2. Click on Participate button, and you will be directed to the survey page.
3. Fill in the survey and submit.
The prevalence of hypertension is a major concern worldwide, affecting a significant proportion of adults aged 30-79 years. Although various treatment options are available, including non-pharmacological and pharmacological approaches, achieving effective control remains a challenge. The primary goal of treatment is to reduce the incidence of cardiovascular mortality and morbidity. Telmisartan, an angiotensin receptor blocker, is widely used due to its unique pharmacokinetic and pharmacodynamic properties, which enable it to modulate the renin-angiotensin system and regulate blood pressure effectively. Compared to other angiotensin receptor blockers, its long-lasting effects make it a favorable treatment option. This survey aims to emphasize the potential benefits, justification, and effectiveness of telmisartan in preventing a range of cardiovascular diseases, including ischemic heart diseases, heart failure and its exacerbations, and coronary artery diseases.
Survey objectives:
1. To evaluate various patient profiles for Telmisartan
2. To understand the tolerability, safety, and efficacy of Telmisartan
3. To establish the role and rationale of sitagliptin use or addition in CV disease prevention and management
4. To derive the best treatment regimen in hypertension management in the best interests of the patient